{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:32:38Z","timestamp":1765355558448},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,2,25]],"date-time":"2011-02-25T00:00:00Z","timestamp":1298592000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bioprocess Biosyst Eng"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s00449-011-0531-1","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T12:02:32Z","timestamp":1298548952000},"page":"811-817","source":"Crossref","is-referenced-by-count":17,"title":["High-level production of a single chain antibody against anthrax toxin in Escherichia coli by high cell density cultivation"],"prefix":"10.1007","volume":"34","author":[{"given":"Ki Jun","family":"Jeong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mridula","family":"Rani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,25]]},"reference":[{"key":"531_CR1","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nbt1142","volume":"23","author":"P Holliger","year":"2005","unstructured":"Holliger P, Hudson PJ (2005) Engineered antibody fragments and the rise of single domains. Nat Biotechnol 23:1126\u20131136","journal-title":"Nat Biotechnol"},{"key":"531_CR2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-1759(03)00100-5","volume":"276","author":"A Hayhurst","year":"2003","unstructured":"Hayhurst A, Happe S, Mabry R, Koch Z, Iverson BL, Georgiou G (2003) Isolation and expression of recombinant antibody fragments to the biological warfare pathogen Brucella melitensis. J Immunol Methods 276:185\u2013196","journal-title":"J Immunol Methods"},{"key":"531_CR3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nbt0602-597","volume":"20","author":"JA Maynard","year":"2002","unstructured":"Maynard JA, Maassen CBM, Leppla SH, Brasky K, Patterson JL, Iverson BL, Georgiou G (2002) Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity. Nat Biotechnol 20:597\u2013601","journal-title":"Nat Biotechnol"},{"key":"531_CR4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/09540109609354900","volume":"8","author":"FR Byrne","year":"1996","unstructured":"Byrne FR, Grant SD, Porter AJ, Harris WJ (1996) Cloning, expression and characterization of a single-chain antibody specific for the herbicide atrazine. Food Agric Immunol 8:19\u201329","journal-title":"Food Agric Immunol"},{"key":"531_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/prep.1999.1164","volume":"18","author":"A Hayhurst","year":"2000","unstructured":"Hayhurst A (2000) Improved expression characteristics of single-chain Fv fragments when fused downstream of the Escherichia coli maltose-binding protein or upstream of a single immunoglobulin-constant domain. Protein Expr Purif 18:1\u201310","journal-title":"Protein Expr Purif"},{"key":"531_CR6","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2144\/03355rr03","volume":"35","author":"Z Zhang","year":"2003","unstructured":"Zhang Z, Song LP, Fang M, Wang F, He D, Zhao R, Liu J, Zhou ZY, Yin CC, Lin Q, Huang HL (2003) Production of soluble and functional engineered antibodies in Escherichia coli improved by FkpA. BioTechniques 35:1032\u20131041","journal-title":"BioTechniques"},{"key":"531_CR7","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1006\/prep.1999.1035","volume":"15","author":"A Hayhurst","year":"1999","unstructured":"Hayhurst A, Harris WJ (1999) Escherichia coli Skp chaperone coexpression improves solubility and phage display of single-chain antibody fragments. Protein Expr Purif 15:336\u2013343","journal-title":"Protein Expr Purif"},{"key":"531_CR8","doi-asserted-by":"crossref","first-page":"9193","DOI":"10.1073\/pnas.0400187101","volume":"101","author":"BR Harvey","year":"2004","unstructured":"Harvey BR, Georgiou G, Hayhurst A, Jeong KJ, Iverson BL, Rogers GK (2004) Anchored periplasmic expression, a versatile technology for the isolation of high-affinity antibodies from Escherichia coli-expressed libraries. Proc Natl Acad Sci USA 101:9193\u20139198","journal-title":"Proc Natl Acad Sci USA"},{"key":"531_CR9","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1128\/IAI.73.12.8362-8368.2005","volume":"73","author":"R Mabry","year":"2005","unstructured":"Mabry R, Rani M, Geiger R, Hubbard GB, Carrion R Jr, Brasky K, Patterson JL, Georgiou G, Iverson BL (2005) Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region. Infect Immun 73:8362\u20138368","journal-title":"Infect Immun"},{"key":"531_CR10","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.clinthera.2009.06.015","volume":"31","author":"A Rivkin","year":"2009","unstructured":"Rivkin A (2009) Certolizumab pegol for the management of Crohn\u2019s disease in adults. Clin Ther 31:1158\u20131176","journal-title":"Clin Ther"},{"key":"531_CR11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0167-7799(96)80930-9","volume":"14","author":"SY Lee","year":"1996","unstructured":"Lee SY (1996) High cell-density culture of Escherichia coli. Trends Biotechnol 14:98\u2013105","journal-title":"Trends Biotechnol"},{"key":"531_CR12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biotechadv.2005.04.004","volume":"23","author":"J Shiloach","year":"2005","unstructured":"Shiloach J, Fass R (2005) Growing E. coli to high cell density\u2014A historical perspective on method development. Biotechnol Adv 23:345\u2013357","journal-title":"Biotechnol Adv"},{"key":"531_CR13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nbt0292-163","volume":"10","author":"P Carter","year":"1992","unstructured":"Carter P, Kelley RF, Rodrigues ML, Snedecor B, Covarrubias M, Velligan MD, Wong WLT, Rowland AM, Kotts CE, Carver ME, Yang M, Bourell JH, Shepard HM, Henner D (1992) High level Escherichia coli expression and production of a bivalent humanized antibody fragment. Nat Biotechnol 10:163\u2013167","journal-title":"Nat Biotechnol"},{"key":"531_CR14","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nbt1193-1271","volume":"11","author":"P Pack","year":"1993","unstructured":"Pack P, Kujau M, Schroeckh V, Knupfer U, Wenderoth R, Riesenberg D, Pluckthun A (1993) Improved bivalent miniantibodies, with identical avidity as whole antibodies, produced by high cell density fermentation of Escherichia coli. Nat Biotechnol 11:1271\u20131277","journal-title":"Nat Biotechnol"},{"key":"531_CR15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1046-5928(02)00543-0","volume":"26","author":"DP Humphreys","year":"2002","unstructured":"Humphreys DP, Carrington B, Bowering LC, Ganesh R, Sehdev M, Smith BJ, King LM, Reeks DG, Lawson A, Popplewell AG (2002) A plasmid system for optimization of Fab\u2019 production in Escherichia coli: importance of balance of heavy chain and light chain synthesis. Protein Expr Purif 26:309\u2013320","journal-title":"Protein Expr Purif"},{"key":"531_CR16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-1759(02)00036-4","volume":"263","author":"LC Simmons","year":"2002","unstructured":"Simmons LC, Reilly D, Klimowski L, Raju TS, Meng G, Sims P, Hong K, Shields RL, Damico LA, Rancatore P, Yansura DG (2002) Expression of full-length immunoglobulins in Escherichia coli: rapid and efficient production of aglycosylated antibodies. J Immunol Methods 263:133\u2013147","journal-title":"J Immunol Methods"},{"key":"531_CR17","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s002530050855","volume":"46","author":"U Horn","year":"1996","unstructured":"Horn U, Strittmatter W, Krebber A, Kn\u00fcpfer U, Kujau M, Wenderoth R, M\u00fcller K, Matzku S, Pl\u00fcckthun A, Riesenberg D (1996) High volumetric yields of functional dimeric miniantibodies in Escherichia coli, using an optimized expression vector and high-cell-density fermentation under non-limited growth conditions. Appl Microbiol Biotechnol 46:524\u2013532","journal-title":"Appl Microbiol Biotechnol"},{"key":"531_CR18","doi-asserted-by":"crossref","first-page":"12430","DOI":"10.1074\/jbc.272.19.12430","volume":"272","author":"G Forsberg","year":"1997","unstructured":"Forsberg G, Forsgren M, Jaki M, Norin M, Sterky C, Enhorning A, Larsson K, Ericsson M, Bjork P (1997) Identification of framework residues in a secreted recombinant antibody fragment that control production level and localization in Escherichia coli. J Biol Chem 272:12430\u201312436","journal-title":"J Biol Chem"},{"key":"531_CR19","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1128\/AEM.70.12.7033-7039.2004","volume":"70","author":"H Sletta","year":"2004","unstructured":"Sletta H, Nedal A, Aune TEV, Hellebust H, Hakvag S, Aune R, Ellingsen TE, Valla S, Brautaset T (2004) Broad-host-range plasmid pJB658 can be used for industrial-level production of a secreted host-toxic single-chain antibody fragment in Escherichia coli. Appl Environ Microbiol 70:7033\u20137039","journal-title":"Appl Environ Microbiol"},{"key":"531_CR20","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1128\/AEM.71.4.1717-1728.2005","volume":"71","author":"IS Aldor","year":"2005","unstructured":"Aldor IS, Krawitz DC, Forrest W, Chen C, Nishihara JC, Joly JC, Champion KM (2005) Proteomic profiling of recombinant Escherichia coli in high-cell-density fermentations for improved production of an antibody fragment biopharmaceutical. Appl Environ Microbiol 71:1717\u20131728","journal-title":"Appl Environ Microbiol"},{"key":"531_CR21","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1128\/AEM.65.7.3027-3032.1999","volume":"65","author":"KJ Jeong","year":"1999","unstructured":"Jeong KJ, Lee SY (1999) High-level production of human leptin by fed-batch cultivation of recombinant Escherichia coli and its purification. Appl Environ Microbiol 65:3027\u20133032","journal-title":"Appl Environ Microbiol"},{"key":"531_CR22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.pep.2003.11.020","volume":"34","author":"S Corisdeo","year":"2004","unstructured":"Corisdeo S, Wang B (2004) Functional expression and display of an antibody Fab fragment in Escherichia coli: study of vector designs and culture conditions. Protein Expr Purif 34:270\u2013279","journal-title":"Protein Expr Purif"},{"key":"531_CR23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pep.2004.04.007","volume":"36","author":"KJ Jeong","year":"2004","unstructured":"Jeong KJ, Choi JH, Yoo WM, Keum KC, Yoo NC, Lee SY, Sung MH (2004) Constitutive production of human leptin by fed-batch culture of recombinant rpoS- Escherichia coli. Protein Expr Purif 36:150\u2013156","journal-title":"Protein Expr Purif"},{"key":"531_CR24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.procbio.2004.01.058","volume":"40","author":"O Durany","year":"2005","unstructured":"Durany O, de Mas C, Lopez-Sant J (2005) Fed-batch production of recombinant fuculose-1-phosphate aldolase in E. coli. Process Biochem 40:707\u2013716","journal-title":"Process Biochem"},{"key":"531_CR25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s004490100267","volume":"24","author":"SC Yim","year":"2001","unstructured":"Yim SC, Jeong KJ, Chang HN, Lee SY (2001) High-level secretory production of human granulocyte-colony stimulating factor by fed-batch culture of recombinant Escherichia coli. Bioprocess Biosyst Eng 24:249\u2013254","journal-title":"Bioprocess Biosyst Eng"},{"key":"531_CR26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1021\/bc049713n","volume":"16","author":"MS Rosendahl","year":"2005","unstructured":"Rosendahl MS, Doherty DH, Smith DJ, Carlson SJ, Chlipala EA, Cox GN (2005) A long-acting, highly potent interferon alpha-2 conjugate created using site-specific PEGylation. Bioconjug Chem 16:200\u2013207","journal-title":"Bioconjug Chem"},{"key":"531_CR27","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1124\/mol.105.014910","volume":"68","author":"S Kubetzko","year":"2005","unstructured":"Kubetzko S, Sarkar CA, Pluckthun A (2005) Protein PEGylation decreases observed target association rates via a dual blocking mechanism. Mol Pharmacol 68:1439\u20131454","journal-title":"Mol Pharmacol"},{"key":"531_CR28","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/protein\/gzg093","volume":"16","author":"K Yang","year":"2003","unstructured":"Yang K, Basu A, Wang M, Chintala R, Hsieh M-C, Liu S, Hua J, Zhang Z, Zhou J, Li M, Phyu H, Petti G, Mendez M, Janjua H, Peng P, Longley C, Borowski V, Mehlig M, Filpula D (2003) Tailoring structure-function and pharmacokinetic properties of single-chain Fv proteins by site-specific PEGylation. Protein Eng 16:761\u2013770","journal-title":"Protein Eng"},{"key":"531_CR29","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1128\/CVI.00023-06","volume":"13","author":"R Mabry","year":"2006","unstructured":"Mabry R, Brasky K, Geiger R, Carrion R, Hubbard GB, Leppla S, Patterson JL, Georgiou G, Iverson BL (2006) Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays. Clin Vaccine Immunol 13:671\u2013677","journal-title":"Clin Vaccine Immunol"},{"key":"531_CR30","doi-asserted-by":"crossref","first-page":"10082","DOI":"10.1073\/pnas.0504556102","volume":"102","author":"KE Griswold","year":"2005","unstructured":"Griswold KE, Kawarasaki Y, Ghoneim N, Benkovic SJ, Iverson BL, Georgiou G (2005) Evolution of highly active enzymes by homology-independent recombination. Proc Natl Acad Sci USA 102:10082\u201310087","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Bioprocess and Biosystems Engineering"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00449-011-0531-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00449-011-0531-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00449-011-0531-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T21:48:00Z","timestamp":1592344080000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00449-011-0531-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,25]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["531"],"URL":"https:\/\/doi.org\/10.1007\/s00449-011-0531-1","relation":{},"ISSN":["1615-7591","1615-7605"],"issn-type":[{"value":"1615-7591","type":"print"},{"value":"1615-7605","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,25]]}}}